You are here: Industry Insights > lupus

News List

Provention Announces Positive Data from Lupus Treatment Study americanpharmaceuticalreview
March 19, 2020
Provention Bio announced positive top-line results from the Phase 1b portion of the PREVAIL (PRV-3279 EVAluation In Lupus) study evaluating PRV-3279 in healthy volunteers.
Peripheral Nervous System Events Not Common in Lupus drugs
January 06, 2020
Peripheral nervous system (PNS) disease is a component of systemic lupus erythematosus (SLE) disease activity and has a significant negative impact on health-related quality of life, according to a study published in the January issue of Arthritis & Rheum
Many Systemic Lupus Erythematosus Patients Use Opioids drugs
September 27, 2019
Patients with systemic lupus erythematosus (SLE) are more likely to use opioids than persons without SLE, and most SLE patients who use opioids do so for more than one year ...
Potential New Lupus Treatment Effectively Reduced Disease Activity in Trial americanpharmaceuticalreview
September 03, 2019
The Lupus Research Alliance has announced a potential new medicine for lupus, anifrolumab, reduced disease activity versus placebo in a second Phase III study.
Exagen and the University of Washington Collaborate on Lupus and Rheumatoid Arthritis Research americanpharmaceuticalreview
August 20, 2019
Exagen Inc., an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention ...
FDA approves first treatment for pediatric patients with lupus worldpharmanews
April 28, 2019
The U.S. Food and Drug Administration approved Benlysta (belimumab) intravenous (IV) infusion for treatment of children with systemic lupus erythematosus (SLE) - often referred to as simply "lupus"
GSK Receives US Approval of Benlysta for Intravenous Use in Children with Lupus Aged Five Years and Above drugs
April 28, 2019
London UK, Philadelphia USA April 26, 2019 -- GSK today announced that the US Food and Drug Administration (FDA) has approved, under priority review, the use of the intravenous (IV) formulation of Benlysta (belimumab) ...
Scans Help Spot Heart Trouble Early in People With Lupus drugs
August 03, 2018
Heart disease is a leading cause of death in patients with the autoimmune illness lupus. Now, research suggests high-tech scans can spot cardiac issues early.
GSK trials Benlysta/rituximab combo for lupus pharmatimes
July 23, 2018
GlaxoSmithKline has kicked off a Phase III trial assessing its lupus drug Benlysta in combination with rituximab in adult patients with the condition.
Lupus Research Alliance and Lupus Therapeutics Collaborate with Bristol-Myers Squibb on a New Lupus Trial biospace
April 27, 2018
The Lupus Research Alliance today announced a collaboration between its newly formed affiliate, Lupus Therapeutics, and the pharmaceutical company, BMS, to test a novel investigational drug, BMS-986165

Previous page 1 2 3 Next page